Literature DB >> 26200044

[Mycoplasma Pneumoniae-Induced Meningoencephalitis].

C Özel1, M Dafotakis1, O Nikoubashman2, J Litmathe1, O Matz1, U Schöne1.   

Abstract

In clinical practice, secondary infections of the central nervous system (CNS) represent rare yet severe complications of their respective primary infections. In this case report, we describe a 22-year-old patient with a medical history of Asthma bronchiale, who developed significant neurological deficits after a respiratory infection. The neurological symptoms progressed despite antibiotic therapy with vancomycin, ampicillin and ceftriaxone. The patient's cerebrospinal fluid and a cranial magnetic resonance imaging (MRI) furnished evidence of acute meningoencephalitis. Microbiological assessment confirmed an acute mycoplasma pneumonia infection. Changing the patient's antibiotic regimen to minocycline and prednisolone led to significant clinical improvement. Pathomechanisms and therapeutic options to treat meningoencephalitis will be discussed in the following. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26200044     DOI: 10.1055/s-0035-1553233

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN: 0720-4299            Impact factor:   0.752


  3 in total

1.  Comparative efficacy and safety of traditional Chinese patent medicine in the treatment of Mycoplasma pneumoniae pneumonia in children: A protocol for systematic review and meta-analysis.

Authors:  Hongan He; Xiao Wang; Yanyan Xiao; Jialin Zheng; Jinjuan Wang; Baoqing Zhang
Journal:  Medicine (Baltimore)       Date:  2020-12-18       Impact factor: 1.817

Review 2.  Pseudomembranous necrotizing laryngotracheobronchitis due to Mycoplasma pneumoniae: a case report and literature review.

Authors:  Wu Lei; Zhang Fei-Zhou; Chen Jing; Li Shu-Xian; Wu Xi-Ling; Tang Lan-Fang
Journal:  BMC Infect Dis       Date:  2022-02-23       Impact factor: 3.090

Review 3.  Insights into the pathogenesis of Mycoplasma pneumoniae (Review).

Authors:  Jun He; Mihua Liu; Zhufeng Ye; Tianping Tan; Xinghui Liu; Xiaoxing You; Yanhua Zeng; Yimou Wu
Journal:  Mol Med Rep       Date:  2016-09-23       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.